Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Plos One
|
June 22, 2016
Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France
Kokuvi Atsou, Perrine Crequit, Christos Chouaid, et al.
Bulletin Du Cancer
|
October 18, 2012
[Supportive cares on thoracic oncology]
Gaëlle Rousseau-Bussac, Perrine Crequit, Marie-José Masanes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2017
Differences in Treatment Effect Size Between Overall Survival and Progression-Free Survival in Immunotherapy Trials: A Meta-Epidemiologic Study of Trials With Results Posted at ClinicalTrials.gov
Aidan Tan, Raphael Porcher, Perrine Crequit, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 19, 2015
Pharmacogenomic biomarkers as inclusion criteria in clinical trials of oncology-targeted drugs: a mapping of ClinicalTrials.gov
Alexandre Vivot, Jacques Li, Jean-David Zeitoun, et al.
BMC Medicine
|
June 12, 2018
Avoidable waste of research related to outcome planning and reporting in clinical trials
Youri Yordanov, Agnes Dechartres, Ignacio Atal, et al.
Bulletin Du Cancer
|
December 23, 2017
[Lung cancer in HIV-infected patients]
Charlotte Domblides, Anthony Canellas, Marie Wislez, et al.
AIDS (London, England)
|
December 2, 2017
Nonsmall cell lung cancer from HIV-infected patients expressed programmed cell death-ligand 1 with marked inflammatory infiltrates
Charlotte Domblides, Martine Antoine, Cécile Hamard, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 11, 2024
Second-line treatment outcomes after first-line chemotherapy plus immunotherapy in Extensive-Stage small cell lung cancer (ES-SCLC) patients: A large French multicenter study
Elvire Pons-Tostivint, Remy Ezzedine, Thomas Goronflot, et al.
Clinical Lung Cancer
|
December 10, 2023
A Multicenter Study Assessing the Real-World Use and Effectiveness of First-Line Chemotherapy Plus Immunotherapy in Advanced Small-Cell Lung Cancer (SCLC) Patients
Marie Porte, Adrien Vaudron, Perrine Crequit, et al.
Clinical Lung Cancer
|
December 12, 2022
Prospective Radiologic-Pathologic Correlation of Macroscopic Volume and Microscopic Extension of Nonsolid Lung Nodules on Thin-section CT Images for Sublobar Resection and Stereotactic Radiotherapy Planning
Arnaud Beddok, Marie-Laure Chabi-Charvillat, Titouan Kennel, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Plos One
|
June 22, 2016
Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France
Kokuvi Atsou, Perrine Crequit, Christos Chouaid, et al.
Bulletin Du Cancer
|
October 18, 2012
[Supportive cares on thoracic oncology]
Gaëlle Rousseau-Bussac, Perrine Crequit, Marie-José Masanes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2017
Differences in Treatment Effect Size Between Overall Survival and Progression-Free Survival in Immunotherapy Trials: A Meta-Epidemiologic Study of Trials With Results Posted at ClinicalTrials.gov
Aidan Tan, Raphael Porcher, Perrine Crequit, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 19, 2015
Pharmacogenomic biomarkers as inclusion criteria in clinical trials of oncology-targeted drugs: a mapping of ClinicalTrials.gov
Alexandre Vivot, Jacques Li, Jean-David Zeitoun, et al.
BMC Medicine
|
June 12, 2018
Avoidable waste of research related to outcome planning and reporting in clinical trials
Youri Yordanov, Agnes Dechartres, Ignacio Atal, et al.
Bulletin Du Cancer
|
December 23, 2017
[Lung cancer in HIV-infected patients]
Charlotte Domblides, Anthony Canellas, Marie Wislez, et al.
AIDS (London, England)
|
December 2, 2017
Nonsmall cell lung cancer from HIV-infected patients expressed programmed cell death-ligand 1 with marked inflammatory infiltrates
Charlotte Domblides, Martine Antoine, Cécile Hamard, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 11, 2024
Second-line treatment outcomes after first-line chemotherapy plus immunotherapy in Extensive-Stage small cell lung cancer (ES-SCLC) patients: A large French multicenter study
Elvire Pons-Tostivint, Remy Ezzedine, Thomas Goronflot, et al.
Clinical Lung Cancer
|
December 10, 2023
A Multicenter Study Assessing the Real-World Use and Effectiveness of First-Line Chemotherapy Plus Immunotherapy in Advanced Small-Cell Lung Cancer (SCLC) Patients
Marie Porte, Adrien Vaudron, Perrine Crequit, et al.
Clinical Lung Cancer
|
December 12, 2022
Prospective Radiologic-Pathologic Correlation of Macroscopic Volume and Microscopic Extension of Nonsolid Lung Nodules on Thin-section CT Images for Sublobar Resection and Stereotactic Radiotherapy Planning
Arnaud Beddok, Marie-Laure Chabi-Charvillat, Titouan Kennel, et al.
Page
of 2